NP0332822 | Proelasnin A1 | | | C18H30O3
294.4350 Da 294.21949 Da | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
NP0332823 | Proelasnin B1 | | | C19H32O3
308.4620 Da 308.23514 Da | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0332824 | Proelasnin C1 | | | C20H34O3
322.4890 Da 322.25079 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0332829 | norflavicansone | | | C17H14Cl2O5
369.1900 Da 368.02183 Da | 1H NMR Spectrum (1D, 500.12300072, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332830 | flavicansone | | | C18H16Cl2O5
383.2200 Da 382.03748 Da | 1H NMR Spectrum (1D, 500.12300072, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332831 | isocaloploicin | | | C17H13Cl3O5
403.6400 Da 401.98286 Da | 1H NMR Spectrum (1D, 500.12300072, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332832 | norvicanicin | | | C17H14Cl2O5
369.1900 Da 368.02183 Da | 1H NMR Spectrum (1D, 500.12300072, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332833 | vicanicin | | | C18H16Cl2O5
383.2200 Da 382.03748 Da | 1H NMR Spectrum (1D, 500.12300072, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332834 | 4-O-methylvicanicin | | | C19H18Cl2O5
397.2500 Da 396.05313 Da | 1H NMR Spectrum (1D, 500.12300072, C3D6O, simulated) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332835 | aurantiamide acetate | | | C28H32N2O4
460.5740 Da 460.23621 Da | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332836 | parietin | | | C16H12O5
284.2635 Da 284.06847 Da | |
NP0332837 | (±)-Penindolene A | | | C19H24N2O4
344.4110 Da 344.17361 Da | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0332838 | (±)-Penindolene B | | | C20H26N2O4
358.4380 Da 358.18926 Da | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0332839 | (±)-Penindolene C | | | C19H24N2O2
312.4130 Da 312.18378 Da | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0332840 | (±)-Penindolene D | | | C20H26N2O2
326.4400 Da 326.19943 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0332842 | Glandicoline B | | | C22H21N5O4
419.4410 Da 419.15935 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 2H NMR Spectrum (1D, 61 MHz, CD3OD, experimental) |
|
NP0332845 | Talaroxanthone | | | C32H30O14
638.5780 Da 638.16356 Da | |
NP0332846 | (±)-Cleichalocimin A1 | | | C28H34O4
434.5760 Da 434.24571 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) |
|
NP0332847 | (±)-Cleichalocimin A2 | | | C28H34O4
434.5760 Da 434.24571 Da | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) |
|
NP0332848 | (±)-Cleichalocimin A4 | | | C28H34O4
434.5760 Da 434.24571 Da | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0332849 | Cleichalcone D | | | C18H16O5
312.3210 Da 312.09977 Da | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 101 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 101 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCL3, experimental) |
|
NP0332850 | Paecillin D | | | C32H30O14
638.5780 Da 638.16356 Da | |
NP0332851 | stylimassalin A | | | C12H13N5O4
291.2670 Da 291.09675 Da | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
NP0332852 | goondansamycin A | | | C19H23NO5
345.3950 Da 345.15762 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332853 | goondansamycin B | | | C25H33NO7
459.5390 Da 459.22570 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|